Medtronic (MDT) Stock Forecast & Price Target

Medtronic
Bull Case

Here are some ways that investors could benefit from investing in Medtronic plc:

• Medtronic plc recently reported strong fiscal 2027 first-quarter results, beating consensus estimates with revenue of $9.76 billion and EPS of $1.45, which exceeded the expected $1.39, demonstrating robust organic growth of 13.7% year-over-year.
• The company has raised its full-year fiscal 2027 guidance, projecting EPS between $5.94 and $6.00, reflecting management's increased confidence in the business trajectory following the strong cardiovascular device performance.
• Medtronic plc offers a dividend yield of 3.17% with a recent quarterly dividend of $0.72 per share, providing a steady income stream for investors while maintaining a payout ratio of 70.94%.
• The stock is currently trading at $90.97, which is below the consensus price target of $98.83, suggesting potential upside as analysts maintain a Moderate Buy rating based on the attractive risk-reward profile.
• Short interest has decreased to 12,134,511 shares, representing a 15.4% drop from the previous month, indicating that investors are covering their short positions and reducing bearish pressure on the stock.